» Articles » PMID: 16455346

6. Asthma: Factors Underlying Inception, Exacerbation, and Disease Progression

Overview
Date 2006 Feb 4
PMID 16455346
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Asthma is a heterogeneous disorder that is characterized by variable airflow obstruction, airway inflammation and hyperresponsiveness, and reversibility either spontaneously or as a result of treatment. Multiple causes no doubt exist for both its inception and symptom exacerbation once the disease is established. Factors underlying inception can range from viral respiratory tract infections in infancy to occupational exposures in adults. Factors underlying asthma exacerbations include allergen exposure in sensitized individuals, viral infections, exercise, irritants, and ingestion of nonsteroidal anti-inflammatory agents among others. Exacerbating factors might include one or all of these exposures and vary both among and within patients. Asthma treatment is determined to a large extent after an assessment of severity, which can be variable over time and assessed in 2 domains: impairment (current) and risk (long-term consequences). Unfortunately, despite the availability of effective therapies, suboptimal asthma control exists in many patients on a worldwide basis. The future development of novel therapies and treatment paradigms should address these disparities.

Citing Articles

Early-Life Exposure to the Great Smog of 1952 and the Development of Asthma.

Bharadwaj P, Graff Zivin J, Mullins J, Neidell M Am J Respir Crit Care Med. 2016; 194(12):1475-1482.

PMID: 27392261 PMC: 5440984. DOI: 10.1164/rccm.201603-0451OC.


Immunomodulatory Effects of Ambroxol on Airway Hyperresponsiveness and Inflammation.

Takeda K, Miyahara N, Matsubara S, Taube C, Kitamura K, Hirano A Immune Netw. 2016; 16(3):165-75.

PMID: 27340385 PMC: 4917400. DOI: 10.4110/in.2016.16.3.165.


The dangers of NSAIDs: look both ways.

Davis A, Robson J Br J Gen Pract. 2016; 66(645):172-3.

PMID: 27033477 PMC: 4809680. DOI: 10.3399/bjgp16X684433.


IL12Rβ1: the cytokine receptor that we used to know.

Robinson R Cytokine. 2014; 71(2):348-59.

PMID: 25516297 PMC: 4346141. DOI: 10.1016/j.cyto.2014.11.018.


Domestic exposure to fungal allergenic particles determined by halogen immunoassay using subject's serum versus particles carrying three non-fungal allergens determined by allergen-specific HIA.

Sercombe J, Liu-Brennan D, McKay K, Green B, Tovey E Indoor Air. 2013; 24(4):438-45.

PMID: 24354925 PMC: 4678322. DOI: 10.1111/ina.12087.


References
1.
Hoffjan S, Nicolae D, Ober C . Association studies for asthma and atopic diseases: a comprehensive review of the literature. Respir Res. 2004; 4:14. PMC: 314398. DOI: 10.1186/1465-9921-4-14. View

2.
Harding S . Gastroesophageal reflux and asthma: insight into the association. J Allergy Clin Immunol. 1999; 104(2 Pt 1):251-9. DOI: 10.1016/s0091-6749(99)70360-x. View

3.
Simons F . Allergic rhinobronchitis: the asthma-allergic rhinitis link. J Allergy Clin Immunol. 1999; 104(3 Pt 1):534-40. DOI: 10.1016/s0091-6749(99)70320-9. View

4.
Platts-Mills T, Vaughan J, Blumenthal K, Pollart Squillace S, Sporik R . Serum IgG and IgG4 antibodies to Fel d 1 among children exposed to 20 microg Fel d 1 at home: relevance of a nonallergic modified Th2 response. Int Arch Allergy Immunol. 2001; 124(1-3):126-9. DOI: 10.1159/000053689. View

5.
Gore C, Custovic A . Preventive measures and their effects. Results from cohort studies. Paediatr Respir Rev. 2002; 3(3):205-18. DOI: 10.1016/s1526-0542(02)00194-x. View